Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
NCT03873584 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-16
Summary
The treatment of anemia depends on its cause. Patients with underlying iron-deficient anemia should be treated or referred to a specialist (eg gynecologist, gastroenterologist) for treatment.deficiency anemia are global health problems and common medical conditions seen in everyday clinical practice.
Iron is vital for biological functions, such as breathing, energy production, DNA synthesis, and cell proliferation.
Iron deficiency refers to the reduction of iron stores and precedes the occurrence of iron deficiency anemia.
Iron deficiency anemia is a more severe condition in which low levels of iron are associated with anemia and the presence of small cellular red blood cells.
Conditions
- Anemia
- Iron-deficiency
- Iron Deficiency Anemia
- Fatigue
Interventions
- OTHER
-
Iron deficiency anemia with fatigue symptoms
Sponsors & Collaborators
-
Elpen Pharmaceutical Co. Inc.
lead INDUSTRY
Eligibility
- Min Age
- 16 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2023-09-30
- Completion
- 2023-09-30
More Related Trials
-
Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants
NCT03359447 ·Status: UNKNOWN ·Phase: PHASE4
-
Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age
NCT01110356 ·Status: COMPLETED ·Phase: PHASE4
-
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
NCT01309659 ·Status: TERMINATED ·Phase: PHASE2
-
Iron Substitution in Blood Donors
NCT01519830 ·Status: COMPLETED ·Phase: PHASE4
-
Amino Acid Chelated Iron Versus Ferrous Fumarate in the Treatment of Iron Deficiency Anemia With Pregnancy: Randomized Controlled Trial
NCT03830034 ·Status: UNKNOWN ·Phase: PHASE4
-
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement
NCT02957643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
NCT00000588 ·Status: COMPLETED ·Phase: PHASE2
-
IRON DEFICIENCY ANEMIA IN RELATION TO PINCH STRENGTH AND HAND DEXTERITY IN PRESCHOOL CHILDREN
NCT05959122 ·Status: COMPLETED
-
Iron Therapy in Erythropoietic Protoporphyria
NCT05572125 ·Status: COMPLETED
-
Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women
NCT02683369 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia
NCT05921968 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia
NCT00069862 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
NCT03037931 ·Status: COMPLETED ·Phase: PHASE3
-
Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia
NCT02518568 ·Status: TERMINATED ·Phase: PHASE1
-
Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
NCT00689793 ·Status: COMPLETED ·Phase: PHASE4
-
Lactoferrin Versus Ferrous Sulfate in Iron-deficiency During Pregnancy
NCT03759353 ·Status: COMPLETED ·Phase: PHASE2
-
L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
NCT00125788 ·Status: COMPLETED ·Phase: PHASE2
-
the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis
NCT03748043 ·Status: UNKNOWN ·Phase: PHASE4
-
The Safety of a High-Dose, Rapid Infusion of Iron Sucrose
NCT02977611 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease
NCT00384657 ·Status: WITHDRAWN ·Phase: PHASE3
-
Iron Deficiency and FGF23 Regulation in CKD and HF
NCT03106298 ·Status: COMPLETED
-
Treatment of Iron Deficiency Anaemia in Pregnancy Study
NCT03725150 ·Status: COMPLETED
-
Tacrolimus Treatment for Refractory Autoimmune Cytopenia
NCT03918265 ·Status: UNKNOWN ·Phase: PHASE4
-
Iron Depletion and Replacement in Blood Donors
NCT01752413 ·Status: COMPLETED ·Phase: NA